Selpercatinib Overcomes CCDC6-RET-Mediated Resistance to Osimertinib.

Shields, Misty D; Hicks, J Kevin; Boyle, Theresa A; Haura, Eric B; Creelan, Benjamin C

Shields, Misty D; Hicks, J Kevin; Boyle, Theresa A; Haura, Eric B; Creelan, Benjamin C.

Afiliación

Shields MD; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; Morsani College of Medicine, University of South Florida, Tampa, Florida. Electronic address: Misty.Shields@moffitt.org.
Hicks JK; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Boyle TA; Department of Pathology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Haura EB; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Creelan BC; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

J Thorac Oncol ; 16(3): e15-e17, 2021 03.

Article en En | MEDLINE | ID: mdl-33641722

Asunto(s)

Neoplasias Pulmonares; Acrilamidas; Compuestos de Anilina; Proteínas del Citoesqueleto; Humanos; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/genética; Proteínas Proto-Oncogénicas c-ret; Pirazoles; Piridinas

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google